Germany Nephrology Biomarkers – A Market Snapshot
Summary
GlobalDatas report, Germany Nephrology Biomarkers – A Market Snapshot provides key information and analysis on the nephrology biomarkers market in Germany. The report provides information on the applications of different biomarkers in the diagnosis of renal failure and monitoring of patients post transplant. The report analyses the market size and volume of key biomarkers such as Serum Creatinine (SCr) and Neutrophil Gelatinase Associated Lipocalin (NGAL) in Germany.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope
- Applications of Biomarkers in the Diagnosis of Kidney Conditions such as Acute Renal Failure and Chronic Kidney Disease.
- Analysis and Comparison of Various Nephrology Biomarkers currently used by physicians.
- Market Sizing and Volumes of Key Nephrology Biomarkers in Germany for the year 2010.
- Key Information on Major Players with Neutrophil Gelatinase Associated Lipocalin (NGAL)-based immunoassays.
- Insights on Possible Trends in the Nephrology Biomarker market due to the demand for early detection of renal failure.
Reasons to buy
- Develop business strategies by understanding the opportunities and unmet needs in the German Nephrology Biomarker market.
- Understand and invest in key enhancements to technology to meet potential client needs in diagnosis of renal failures.
- Design and develop your marketing and sales strategies
- Develop market expansion strategies.
- Exploit M&A opportunities by identifying key areas of growth.
1 Table of Contents
1 Table of Contents 1
1.1 List of Tables 1
1.2 List of Figures 1
2 Summary 1
3 Germany Nephrology Biomarkers A Market Snapshot 1
3.1 Nephrology Biomarkers, Applications 1
3.1.1 Diagnostic Tests for Renal Failure 2
3.1.2 Use of Biomarkers in Post Transplant Therapeutic Drug Monitoring (TDM) Practices 3
3.2 Nephrology Biomarkers, Comparison by Type 3
3.2.1 Other Types of Biomarkers Used 3
3.3 Germany Nephrology Biomarkers: Market Characterization 4
3.3.1 Nephrology Biomarkers (SCr) Market, Germany, Revenue ($m) and Volume (000), by Site, 2010 4
3.3.2 Nephrology Biomarkers (NGAL) Market, Germany, Revenue ($000) and Volume (000), by Site, 2010 4
3.3.3 Nephrology Biomarkers (NGAL) Market, Germany, Key Players and Products, 2010 5
4 Appendix 5
4.1 Research Methodology 6
4.2 Secondary Research 6
4.3 Primary Research 6
4.4 Models 6
4.5 Forecasts 7
4.6 Expert Panels 7
4.7 GlobalData Consulting 7
4.8 Contact Us 7
4.9 Disclaimer 7
List of Table:1.1 List of Tables
Table 1: List of Other Potential Biomarkers Used in Nephrology, 2010 3
Table 2: Nephrology Biomarkers (SCr) Market, Germany, Market Size ($m), Volume (000), by Care Setting, 2010 4
Table 3: Nephrology Biomarkers (NGAL) Market, Germany, Revenue ($000), Volume (000), by Care-Setting, 2010 5
Table 4: Nephrology Biomarkers (NGAL) Market, Germany, Key Players and Products, 2010 5
List of Charts:1.2 List of Figures
Figure 1: Nephrology Biomarkers, Comparison, by Type 3
Figure 2: Nephrology Biomarkers (SCr) Market, Germany, Revenue ($m), Volume (000), by Care Setting, 2010 4
Figure 3: Nephrology Biomarkers (NGAL) Market, Germany, Revenue ($000), Volume (000), by Care-Setting, 2010 4
Biomarkers in Drug Discovery – Optimizing Drug Discovery Timeline and Costs
Biomarkers in Cancer Research – High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
No related posts.
Germany Nephrology Biomarkers – A Market SnapshotBuy This Report Now Call US : USA-CANADA Toll Free: +1-866-997-948 or +1-518-618-1030 Email: sales@twease.org |
Request Sample on This Report
|